SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers is trending amid increased competition in the weight loss market, with Amazon Pharmacy now offering Novo Nordisk's Wegovy, a GLP-1 drug not available on HIMS's platform, compounded by a Bank of America downgrade citing concerns over 2026 margins. This has fueled widespread bearish sentiment and predictions of further stock declines, though some investors view it as an oversold opportunity, highlighting the company's long-term growth strategy across various healthcare verticals and international expansion.

NovaBay Pharmaceuticals, Inc. engages in the development and sales of scientifically-created and clinically-proven eyecare and skincare. Its products include Avenova, NeutroPhase and DERMAdoctor. The company was founded on January 19, 2000 and is headquartered in Emeryville, CA.

Novabay Pharmaceuticals Inc

Novabay Pharmaceuticals Inc. is witnessing extreme trading activity, primarily driven by a substantial special cash dividend and strong speculation of a short squeeze. The community is intensely focused on the company's evolving strategy to include blockchain-based assets and its leadership's track record of corporate turnarounds. This has ignited both fervent bullish sentiment and significant skepticism regarding the sustainability of its rapid price movement.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is a trending topic as significant share grants to CEO Michael Weiss have sparked intense debate among investors, leading to accusations of greed while also prompting discussions of potential short manipulation. The community remains focused on Briumvi's strong market performance, recent competitor setbacks, and high anticipation for strategic updates or acquisition speculation heading into the J.P. Morgan Healthcare Conference.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo Inc. is trending following a significant agreement with Meta Platforms to develop a 1.2 GW nuclear energy campus for AI data centers in Ohio, which investors are hailing as a major validation for its advanced reactor technology. The community is actively discussing the long-term potential of nuclear power to meet AI's massive energy demands and speculating on impending DOE plutonium awards, while skeptics highlight the company's zero revenue and distant timelines for operational power production.

Terrestrial Energy, Inc. is an advanced nuclear technology company focused on next-generation nuclear energy systems. The company is developing the Integral Molten Salt Reactor (IMSR), an innovative type of Generation IV molten salt reactor designed to produce reliable, low-carbon heat and electricity at competitive costs. The company is headquartered in Charlotte, NC.

Terrestrial Energy Inc.

Terrestrial Energy (IMSR) is trending due to its recent agreement with the U.S. Department of Energy for Project TETRA, a key step towards constructing and operating a pilot molten salt reactor. The community is actively discussing its advanced regulatory progress and perceived valuation disconnect compared to other nuclear innovators like OKLO, with many anticipating significant long-term upside as advanced nuclear solutions become crucial for increasing energy demand, including from AI infrastructure.

Datadog, Inc. engages in the development of a monitoring and analytics platform for developers, information technology operations teams and business users. Its platform integrates and automates infrastructure monitoring, application performance monitoring and log management to provide real-time observability of its customers' entire technology stack. The company was founded by Olivier Pomel and Alexis Lê-Quôc on June 4, 2010 and is headquartered in New York, NY.

Datadog Inc - Ordinary Shares - Class A

Datadog Inc

Datadog is trending amid significant price volatility, as recent strong earnings were followed by a sharp decline, attributed by some to institutional profit-taking and an analyst downgrade. The community is actively discussing heightened competition in the observability sector, particularly from a rival's rumored acquisition, while also seeing the current levels as a compelling buying opportunity given Datadog's robust AI integrations and sticky revenue. Adding to the buzz, there are circulating rumors about Datadog itself exploring a potential takeover bid for GitLab.

Rich Sparkle Holdings Ltd. engages in the provision of financial printing and corporate services. The firm offers typesetting, proofreading, translation, design, and printing of listing documents, financial reports, fund documents, circulars, and announcements. It also delivers advisory services, such as conducting internal control assessment and environmental, social and governance performance evaluation, and other services including provision of co-working space. The company was founded in 2016 and is headquartered in Hong Kong.

Rich Sparkle Holdings Ltd.

Rich Sparkle Holdings Limited

Rich Sparkle Holdings Limited (ANPA) is experiencing significant market momentum, largely driven by its recent IPO lock-up expiration which has ignited a short squeeze narrative among retail traders. The community is actively discussing its potential for parabolic gains, drawing comparisons to other volatile 'Hong Kong' listed stocks, though some express caution regarding pump and dump characteristics. Further speculative interest stems from news of a substantial private placement or acquisition plans.

Zcash is a privacy-focused cryptocurrency that uses trustless zero-knowledge proofs to enable fully encrypted transactions while maintaining blockchain transparency and security. It was the first cryptocurrency to implement zero-knowledge encryption for private peer-to-peer payments, addressing the fundamental privacy gap in traditional cryptocurrencies that expose transaction details publicly.   With a fixed supply of 21 million ZEC and a halving schedule similar to Bitcoin, Zcash allows users to prove transactions are valid without revealing sensitive information like wallet balances, transaction amounts, or participant identities, making it suitable for everyday payments, long-term savings, and cross-border money transfers where financial confidentiality matters.  The protocol operates on its own blockchain currently using Proof-of-Work consensus, though it's evolving toward Proof-of-Stake through the planned "Crosslink" upgrade to enhance security, scalability, and energy efficiency. Zcash employs trustless zero-knowledge proofs (Halo) within its Orchard shielded pool to verify transactions without revealing sender, receiver, or amount information.   Users can choose between transparent public transactions and shielded private transactions through Unified Addresses, which work with both types. The network is faster and cheaper than Bitcoin, with new blocks mined every 75 seconds and transaction fees typically just a fraction of a cent. Privacy adoption has surged in 2025, with over 30% of total ZEC supply now held in fully shielded pools.  Zcash was created by a group of scientists in 2013 who initially proposed Zerocoin as a privacy extension to Bitcoin before building a standalone protocol. The ecosystem operates with a self-funded development model where block rewards support independent teams through the Zcash Community Grants Committee and a new Coinholder-Controlled Fund.

Zcash

ZEC is actively trending amid intense community debate surrounding a developer team organizational shift, which many are reframing as a strategic pivot rather than an abandonment. This reinterpretation is buoyed by Nasdaq-listed Cypherpunk Technologies significantly increasing its ZEC treasury holdings and a Grayscale spot ETF filing, fueling optimism for Zcash's privacy mission and institutional prospects.

The Cosmos network consists of many independent, parallel blockchains, called zones, each powered by classical Byzantine fault-tolerant (BFT) consensus protocols like Tendermint. Some zones act as hubs with respect to other zones, allowing many zones to interoperate through a shared hub. The architecture uses classic BFT and Proof-of-Stake algorithms, instead of Proof-of-Work. Cosmos can interoperate with multiple other applications and cryptocurrencies, something other blockchains can’t do well. By creating a new zone, you can plug any blockchain system into the Cosmos hub and pass tokens back and forth between those zones, without the need for an intermediary.  While the Cosmos Hub is a multi-asset distributed ledger, there is a special native token called the atom. ATOM have three use cases: as a spam-prevention mechanism, as staking tokens, and as a voting mechanism in governance.  As a spam prevention mechanism, ATOM are used to pay fees. The fee may be proportional to the amount of computation required by the transaction, similar to Ethereum’s concept of “gas”. Fee distribution is done in-protocol and a protocol specification is described here.  As staking tokens, ATOM can be “bonded” in order to earn block rewards. The economic security of the Cosmos Hub is a function of the amount of ATOM staked. The more ATOM that are collateralized, the more “skin” there is at stake and the higher the cost of attacking the network. Thus, the more ATOM there are bonded, the greater the economic security of the network.  Atom holders may govern the Cosmos Hub by voting on proposals with their staked ATOM.

Cosmos

Cosmos (ATOM) is trending amid active discussions surrounding a proposed tokenomics redesign aimed at transitioning to a revenue-based model, alongside recent speculation about potential ETF filings for its ecosystem. This comes as the community remains divided, with strong bullish sentiment from those attracted to its high staking rewards and role as the 'Internet of Blockchains,' while others express skepticism over past price performance and its ability to keep pace with broader market rallies.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending after news of CEO Ryan Cohen's performance-based compensation, which ties his pay to ambitious market capitalization and EBITDA targets, alongside ongoing strategic store closures. This has ignited debate among investors, with bulls seeing it as a strong alignment of interests signaling significant future growth, while skeptics view the targets as unrealistic given past stock performance and the company's current trajectory.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Wall Street Zen Upgrades Palisade Bio (NASDAQ:PALI) to "Hold"

Wall Street Zen raised shares of Palisade Bio from a "sell" rating to a "hold" rating in a research note on Saturday...

Palisade Bio, Inc. (NASDAQ:PALI) Receives Consensus Rating of "Moderate Buy" from Analysts

Shares of Palisade Bio, Inc. (NASDAQ:PALI - Get Free Report) have been assigned an average rating of "Moderate Buy" from the five brokerages that are presently covering the company, Marketbeat.com...

Palisade Bio (NASDAQ:PALI) Stock Rating Upgraded by Clear Str

Clear Str raised shares of Palisade Bio to a "strong-buy" rating in a report on Monday...

Palisade Bio (NASDAQ:PALI) Upgraded at Piper Sandler

Piper Sandler upgraded shares of Palisade Bio to a "strong-buy" rating in a report on Monday...

Palisade Bio (NASDAQ:PALI) Stock Rating Lowered by Wall Street Zen

Wall Street Zen downgraded Palisade Bio from a "hold" rating to a "sell" rating in a research note on Saturday...

Palisade Bio (PALI) Upgraded to Buy: Here's What You Should Know

Palisade Bio (PALI) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Palisade Bio (NASDAQ:PALI) Trading Up 0.6% - Here's What Happened

Palisade Bio (NASDAQ:PALI) Stock Price Up 0.6% - Should You Buy...

FY2025 EPS Estimate for Palisade Bio Increased by Analyst

Palisade Bio, Inc. (NASDAQ:PALI - Free Report) - Analysts at Brookline Capital Management upped their FY2025 earnings per share estimates for shares of Palisade Bio in a research note issued to...

Palisade Bio (NASDAQ:PALI) Announces Earnings Results, Misses Estimates By $0.06 EPS

Palisade Bio (NASDAQ:PALI - Get Free Report) issued its earnings results on Monday. The company reported ($0.38) earnings per share for the quarter, missing the consensus estimate of ($0.32) by...

Here's Why Palisade Bio (PALI) Could be Great Choice for a Bottom Fisher

After losing some value lately, a hammer chart pattern has been formed for Palisade Bio (PALI), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.

This account has been verified as an official PALI representative.

Verified Account

Palisade Bio

Palisade Bio, Inc. is a biopharmaceutical company, which engages in the development of oral therapies that help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. It offers LB1148, an oral formulation of a broad-spectrum serine protease inhibitor designed to neutralize the activity of potent digestive proteases released from the gut during surgery. The company was founded on September 6, 2011 and is headquartered in Carlsbad, CA.

Palisade Bio Inc

Yes — Rates Move Meaningfully Lower

Short-Term Dip, No Lasting Impact

No — Mostly Political Noise

Other – Comment Below

President Trump says he’s directing $200 billion into mortgage bond purchases to bring down rates and improve housing affordability. With questions around execution, authority, and real market impact, do you think this move will actually lower mortgage rates in 2026?

Will Trump’s Mortgage Bond Plan Actually Lower Rates in 2026?

Current Price	$1.99
Prev Close	$1.90
Open	$1.97
Dividend Yield	0.00%
50-Day Moving Average	$2.00
Beta	1.11
Avg. Volume	5.78M
PE Ratio	-0.45

52-Week High	$2.64
52-Week Low	$0.53
Market Capitalization	$283.11M
EPS (Annual)	-$10.19
Price to Book	5.40
Revenue Per Employee	$0.00
Enterprise Value/EBITDA	N/A

PALI
Palisade Bio Inc

Feed

News

Sentiment

Fundamentals

Info

Latest PALI News

PALIPalisade Bio Inc